FI111805B - Menetelmä valmistaa silmissä tai nenässä käytettävä allergiaa torjuva koostumus - Google Patents

Menetelmä valmistaa silmissä tai nenässä käytettävä allergiaa torjuva koostumus Download PDF

Info

Publication number
FI111805B
FI111805B FI935851A FI935851A FI111805B FI 111805 B FI111805 B FI 111805B FI 935851 A FI935851 A FI 935851A FI 935851 A FI935851 A FI 935851A FI 111805 B FI111805 B FI 111805B
Authority
FI
Finland
Prior art keywords
cyclodextrin
solution
composition
cetirizine
process according
Prior art date
Application number
FI935851A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI935851A (fi
FI935851A0 (fi
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of FI935851A0 publication Critical patent/FI935851A0/fi
Publication of FI935851A publication Critical patent/FI935851A/fi
Application granted granted Critical
Publication of FI111805B publication Critical patent/FI111805B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI935851A 1992-12-25 1993-12-23 Menetelmä valmistaa silmissä tai nenässä käytettävä allergiaa torjuva koostumus FI111805B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25
JP34603192 1992-12-25

Publications (3)

Publication Number Publication Date
FI935851A0 FI935851A0 (fi) 1993-12-23
FI935851A FI935851A (fi) 1994-06-26
FI111805B true FI111805B (fi) 2003-09-30

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935851A FI111805B (fi) 1992-12-25 1993-12-23 Menetelmä valmistaa silmissä tai nenässä käytettävä allergiaa torjuva koostumus

Country Status (23)

Country Link
US (1) US5419898A (fr)
EP (1) EP0605203B1 (fr)
JP (1) JP3683595B2 (fr)
KR (1) KR100276743B1 (fr)
CN (1) CN1050514C (fr)
AT (1) ATE164068T1 (fr)
AU (1) AU666413B2 (fr)
BG (1) BG61101B1 (fr)
CA (1) CA2112014C (fr)
CZ (1) CZ283029B6 (fr)
DE (1) DE69317537T2 (fr)
DK (1) DK0605203T3 (fr)
ES (1) ES2115733T3 (fr)
FI (1) FI111805B (fr)
HU (2) HU218672B (fr)
LT (1) LT3344B (fr)
LV (1) LV10688B (fr)
NO (2) NO934630D0 (fr)
NZ (1) NZ250519A (fr)
PL (1) PL173347B1 (fr)
RU (1) RU2130774C1 (fr)
SK (1) SK279503B6 (fr)
TW (1) TW401300B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (fr) * 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2001501212A (ja) * 1996-09-27 2001-01-30 ナステック ファーマシューティカル カンパニー インク 睡眠促進用鼻腔内調製物及び同物を用いる方法
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (fr) * 1997-11-26 1999-06-02 Ucb, S.A. Formes pseudopolymorphiques de l'acide 2-2-4-bis(4-fluorophényl)méthyl -1-pipérazinyl-éthoxy acétique dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
JP2002523475A (ja) 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
PL212123B1 (pl) * 2002-01-15 2012-08-31 Ucb Farchim Sa Doustna kompozycja farmaceutyczna
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (es) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Sistema de suministro de compuesto terapéutico oral
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
EP1771161B1 (fr) * 2004-07-22 2010-04-21 Bend Research, Inc Formulation de masquage du gout comprenant un medicament a dissolution retardee et/ou de la cyclodextrine a dissolution amelioree
EP2325171B1 (fr) 2005-05-26 2013-10-09 Aldexa Therapeutics, Inc. Dérivés de quinoline pour le traitement des maladies rétiniennes
JPWO2006137433A1 (ja) * 2005-06-21 2009-01-22 わかもと製薬株式会社 レボカバスチンを可溶化させた水性薬剤
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
CN104224704A (zh) * 2006-03-13 2014-12-24 株式会社·R-技术上野 水性组合物
WO2008025560A1 (fr) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Procédés servant à masquer le goût de compositions nébulisées pour thérapie par inhalation nasale et pulmonaire
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
PT2408453T (pt) * 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
WO2011017909A1 (fr) * 2009-08-12 2011-02-17 鲁南贝特制药有限公司 Solution pharmaceutique de chlorhydrate de cetirizine
BR112012010658A2 (pt) 2009-11-06 2015-10-06 Univ Yale composições anfifílicas e processos para preparação e emprego das mesmas
DK2785352T3 (da) 2011-11-29 2020-05-25 Jurox Pty Ltd Stabile injicerbare farmaceutiske sammensætninger omfattende 2-hydroxypropyl-beta-cyclodextrin og alfaxalon
KR102435676B1 (ko) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
WO2017035077A1 (fr) 2015-08-21 2017-03-02 Aldeyra Therapeutics, Inc. Composés deutérés et leurs utilisations
CN109069530A (zh) * 2016-02-28 2018-12-21 奥尔德拉医疗公司 用环糊精治疗过敏性眼部病状
CA3022665A1 (fr) 2016-05-09 2017-11-16 Aldeyra Therapeutics, Inc. Polytherapie de troubles et de maladies inflammatoires oculaires
JP6843896B2 (ja) * 2017-02-13 2021-03-17 日東メディック株式会社 水性点眼点鼻用組成物
CA3054811A1 (fr) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Composes polymorphes et leurs utilisations
CN111356451A (zh) 2017-10-10 2020-06-30 奥尔德拉医疗公司 炎性病症的治疗
CA3088740A1 (fr) * 2018-01-18 2019-07-25 Faes Farma, S.A. Compositions ophtalmiques comprenant de la bilastine, une beta-cyclodextrine et au moins un agent gelifiant
WO2020033344A1 (fr) 2018-08-06 2020-02-13 Aldeyra Therapeutics, Inc. Composés polymorphes et leurs utilisations
US11197821B2 (en) 2018-09-25 2021-12-14 Aldeyra Therapeutics, Inc. Formulations for treatment of dry eye disease
JP2022526917A (ja) 2019-03-26 2022-05-27 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
JPH06239748A (ja) 1994-08-30
EP0605203A2 (fr) 1994-07-06
CN1050514C (zh) 2000-03-22
CZ283029B6 (cs) 1997-12-17
NO304176B1 (no) 1998-11-09
JP3683595B2 (ja) 2005-08-17
ES2115733T3 (es) 1998-07-01
FI935851A (fi) 1994-06-26
CA2112014A1 (fr) 1994-06-26
HUT69385A (en) 1995-09-28
KR940013511A (ko) 1994-07-15
NZ250519A (en) 1995-03-28
BG98327A (bg) 1994-08-30
EP0605203A3 (fr) 1994-11-02
SK279503B6 (sk) 1998-12-02
HU218672B (hu) 2000-10-28
TW401300B (en) 2000-08-11
PL173347B1 (pl) 1998-02-27
DK0605203T3 (da) 1998-12-07
CZ283693A3 (en) 1994-07-13
NO934630D0 (no) 1993-12-15
LTIP1669A (en) 1994-10-25
LV10688B (en) 1995-10-20
AU666413B2 (en) 1996-02-08
KR100276743B1 (ko) 2001-01-15
LV10688A (lv) 1995-06-20
CN1094614A (zh) 1994-11-09
NO934630L (no) 1994-06-27
SK147493A3 (en) 1994-07-06
HU211972A9 (en) 1996-01-29
PL301588A1 (en) 1994-06-27
LT3344B (en) 1995-07-25
US5419898A (en) 1995-05-30
DE69317537T2 (de) 1998-07-09
BG61101B1 (bg) 1996-11-29
FI935851A0 (fi) 1993-12-23
RU2130774C1 (ru) 1999-05-27
EP0605203B1 (fr) 1998-03-18
HU9303746D0 (en) 1994-04-28
DE69317537D1 (de) 1998-04-23
CA2112014C (fr) 2004-11-02
AU5259793A (en) 1994-07-07
ATE164068T1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
FI111805B (fi) Menetelmä valmistaa silmissä tai nenässä käytettävä allergiaa torjuva koostumus
KR100889170B1 (ko) 안구 건조의 치료에 있어서 리멕솔론의 용도
KR101689924B1 (ko) 고농도 올로파타딘 안과용 조성물
EP2785328B1 (fr) Nouvelles compositions ophtalmiques à libération lente comprenant de la povidone iodée
JPH1160505A (ja) 防腐組成物
JP2003026575A (ja) 医薬組成物
JP6770436B2 (ja) 高浸透圧ヒアルロン酸組成物
JP4904687B2 (ja) 眼科用組成物
CN115701986A (zh) 包含地夸磷索的眼用组合物
JP2005008596A (ja) 眼科用組成物
JPH1036255A (ja) 眼圧降下用点眼剤
JP2004168709A (ja) 抗アレルギー点眼点鼻用組成物
JPH02262518A (ja) 眼圧調整剤
JP2005053825A (ja) 点眼点鼻用組成物